REVA to Present at 31st Annual J.P. Morgan Healthcare Conference
04 January 2013 - 11:57AM
REVA Medical, Inc. (ASX:RVA) ("REVA" or the "Company") is pleased
to announce that its Chairman and CEO, Robert Stockman, is
presenting at the 31st Annual J.P. Morgan Healthcare Conference at
1:30 p.m. US PST on Thursday, January 10, 2013. The conference is
being held January 7 through 10, 2013 at The Westin St. Francis
Hotel in San Francisco, California.
A copy of the presentation materials will be available on REVA's
website at www.revamedical.com shortly before the presentation.
About REVA
REVA is a development stage medical device company incorporated
in Delaware, USA, that is focused on the development and eventual
commercialization of its proprietary bioresorbable stent products.
REVA's initial product, the ReZolveĀ® scaffold, which is in a
clinical study phase, combines REVA's proprietary stent design with
a proprietary polymer that is metabolized and cleared from the
body. The ReZolve scaffold is designed to offer full x-ray
visibility, clinically relevant sizing, and a controlled and safe
resorption rate. In addition, by early encapsulation of the stent
in the artery tissue coupled with the loss of scaffold structure
over time, the ReZolve scaffold may reduce the incidence of late
forming blood clots or otherwise reduce long-term disease
progression, potential benefits of bioresorbable scaffolds that
have yet to be proven. REVA will require clinical results and
regulatory approval before it can begin selling the ReZolve
scaffold.
The REVA Medical, Inc. logo is available at
http://www.globenewswire.com/newsroom/prs/?pkgid=8505
CONTACT: United States
Investor and Media Enquiries:
Cheryl Liberatore
Director, Investor Relations and Marketing
REVA Medical, Inc.
+1 858 966-3045
Australia
Investor Enquiries:
Kim Jacobs or Alan Taylor
Inteq Limited
+61 2 9231 3322
Media Enquiries:
Haley Price or Rebecca Wilson
Buchan Consulting
+61 3 9866 4722
Reva Medical (ASX:RVA)
Historical Stock Chart
From Dec 2024 to Dec 2024
Reva Medical (ASX:RVA)
Historical Stock Chart
From Dec 2023 to Dec 2024
Real-Time news about Reva Medical Inc (Australian Stock Exchange): 0 recent articles
More REVA Medical, Inc. News Articles